 "Trivitron Healthcare aims at sales of Rs 1,000 cr by FY15")
Medical devices maker Trivitron Healthcare is aiming to achieve revenues of Rs 1,000 crore in the next financial year mainly on account of increasing presence in imaging and diagnostic segments.
"We plan to achieve a target of Rs 1,000 crore in sales in FY 15. We expect the imaging, diagnostics and cardiac implantable devices to be the main drivers of growth for the company," Trivitron Healthcare Managing Director G S K Velu told PTI.
The Chennai-based company is looking at sales of up to Rs 750 crore for the current fiscal year, up from Rs around 600 crore in the last fiscal, he added.
Also Read
"We are targeting both -- the domestic as well as export markets, with mainly emerging countries to be the prime contributors for growth," Velu said.
The key emerging markets for the company are Latin America, South Asia, South East Asia, Middle East, Africa and Russia.
"At present around half of our revenues and almost 80% of our profits are coming from overseas operations," he added.
The company is also open to taking inorganic path for expansion and had acquired Finland-based Ani Labsystems in November last year.
"We will be taking both organic and inorganic routes for expansion and are open to partnerships, joint ventures and acquisitions," Velu said.
The cardiac implantable devices will be one of the main focus areas of the company in future, he added.
Trivitron Healthcare currently has eight manufacturing facilities, including one at Helsinki in Finland. It exports products to over 160 countries.
The company is present in the segments of cardiology and implantable devices, imaging diagnostics, laboratory diagnostics, ophthalmology, critical care and dental implants & equipment among others.